| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 3.45e-05 | 65 | 189 | 6 | GO:0004714 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 7.33e-05 | 145 | 189 | 8 | GO:0004713 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 7.84e-05 | 188 | 189 | 9 | GO:0005201 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.56e-04 | 85 | 189 | 6 | GO:0019199 | |
| GeneOntologyCellularComponent | extracellular matrix | ADAMTS19 LAMA1 EMILIN3 COL22A1 HRNR FCGBP CLC PXDN SPARCL1 CILP CPZ VWA1 FREM3 ANGPTL6 VCAN MUC4 TNXB CTSS OTOG | 9.07e-06 | 656 | 190 | 19 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | ADAMTS19 LAMA1 EMILIN3 COL22A1 HRNR FCGBP CLC PXDN SPARCL1 CILP CPZ VWA1 FREM3 ANGPTL6 VCAN MUC4 TNXB CTSS OTOG | 9.47e-06 | 658 | 190 | 19 | GO:0030312 |
| GeneOntologyCellularComponent | postsynaptic specialization | EPS8 PDE4B DAPK1 KCND2 NR3C2 DGCR8 BSN DPYSL2 DTNB DVL1 GRIN2B AKAP9 CELSR3 SIPA1L1 PRNP | 5.95e-05 | 503 | 190 | 15 | GO:0099572 |
| GeneOntologyCellularComponent | multi-pass translocon complex | 5.96e-05 | 9 | 190 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | postsynaptic density | EPS8 PDE4B DAPK1 NR3C2 DGCR8 BSN DPYSL2 DTNB DVL1 GRIN2B AKAP9 CELSR3 SIPA1L1 PRNP | 6.89e-05 | 451 | 190 | 14 | GO:0014069 |
| GeneOntologyCellularComponent | neuron to neuron synapse | EPS8 PDE4B DAPK1 NRXN1 NR3C2 DGCR8 BSN DPYSL2 DTNB DVL1 GRIN2B AKAP9 CELSR3 SIPA1L1 PRNP | 9.20e-05 | 523 | 190 | 15 | GO:0098984 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | LAMA1 EMILIN3 COL22A1 HRNR CLC PXDN SPARCL1 CILP VWA1 FREM3 ANGPTL6 VCAN MUC4 TNXB CTSS | 1.06e-04 | 530 | 190 | 15 | GO:0062023 |
| GeneOntologyCellularComponent | asymmetric synapse | EPS8 PDE4B DAPK1 NR3C2 DGCR8 BSN DPYSL2 DTNB DVL1 GRIN2B AKAP9 CELSR3 SIPA1L1 PRNP | 1.24e-04 | 477 | 190 | 14 | GO:0032279 |
| GeneOntologyCellularComponent | cell surface | PDGFRB SIGLEC8 INSR HLA-E ADGRV1 F10 PXDN NRXN1 PTPRJ BSN LILRB5 SLAMF9 GRIN2B CR2 AREG TIGIT VCAN BTN2A3P CD44 IL2RG CTSS PRNP EPHA5 | 1.98e-04 | 1111 | 190 | 23 | GO:0009986 |
| GeneOntologyCellularComponent | ER membrane insertion complex | 2.50e-04 | 14 | 190 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | axon | EPS8 KIF1B INSR NRXN1 C4A C4B BSN ALK TRIM46 DPYSL2 DVL1 GRIN2B SYDE1 TENM3 NPTXR AP3B2 PARD3 PRNP EPHA5 | 5.09e-04 | 891 | 190 | 19 | GO:0030424 |
| GeneOntologyCellularComponent | extrinsic component of membrane | 1.24e-03 | 230 | 190 | 8 | GO:0019898 | |
| Domain | CarboxyPept-like_regulatory | 1.15e-08 | 17 | 190 | 6 | IPR008969 | |
| Domain | Ig-like_fold | EPHB4 IGFN1 PDGFRB SIGLEC8 INSR HLA-E PXDN PTPRJ NOMO2 NFKB1 SDK1 LILRB5 TRIM46 SLAMF9 CILP VWA1 NOMO1 TIGIT TIE1 VCAN BTN2A3P IL2RG TNXB NOMO3 EPHA5 | 5.76e-08 | 706 | 190 | 25 | IPR013783 |
| Domain | - | EPHB4 IGFN1 PDGFRB SIGLEC8 INSR HLA-E PXDN PTPRJ NOMO2 NFKB1 SDK1 LILRB5 TRIM46 SLAMF9 CILP VWA1 NOMO1 TIGIT TIE1 VCAN IL2RG TNXB NOMO3 EPHA5 | 7.23e-08 | 663 | 190 | 24 | 2.60.40.10 |
| Domain | EGF-like_dom | LAMA1 F10 FCGBP NRXN1 AREG CRB1 CELSR3 CELSR2 TENM3 TIE1 VCAN MUC4 TNXB OTOG | 2.72e-07 | 249 | 190 | 14 | IPR000742 |
| Domain | EGF-like_CS | EPHB4 LAMA1 F10 NRXN1 AREG CRB1 CELSR3 CELSR2 TENM3 TIE1 VCAN MUC4 TNXB EPHA5 | 4.82e-07 | 261 | 190 | 14 | IPR013032 |
| Domain | EGF_2 | EPHB4 LAMA1 F10 NRXN1 AREG CRB1 CELSR3 CELSR2 TENM3 TIE1 VCAN MUC4 TNXB EPHA5 | 5.78e-07 | 265 | 190 | 14 | PS01186 |
| Domain | EGF | 6.50e-07 | 126 | 190 | 10 | PF00008 | |
| Domain | fn3 | EPHB4 IGFN1 INSR PTPRJ SDK1 TRIM46 VWA1 TIE1 IL2RG TNXB EPHA5 | 8.50e-07 | 162 | 190 | 11 | PF00041 |
| Domain | EGF | LAMA1 F10 FCGBP NRXN1 AREG CRB1 CELSR3 CELSR2 TENM3 TIE1 VCAN MUC4 TNXB | 8.84e-07 | 235 | 190 | 13 | SM00181 |
| Domain | FN3 | EPHB4 IGFN1 INSR PTPRJ SDK1 TRIM46 VWA1 TIE1 IL2RG TNXB EPHA5 | 3.13e-06 | 185 | 190 | 11 | SM00060 |
| Domain | DUF2012 | 4.11e-06 | 4 | 190 | 3 | PF09430 | |
| Domain | DUF2012 | 4.11e-06 | 4 | 190 | 3 | IPR019008 | |
| Domain | EGF_3 | F10 NRXN1 AREG CRB1 CELSR3 CELSR2 TENM3 TIE1 VCAN MUC4 TNXB OTOG | 5.37e-06 | 235 | 190 | 12 | PS50026 |
| Domain | - | 5.65e-06 | 95 | 190 | 8 | 2.60.120.200 | |
| Domain | FN3 | EPHB4 IGFN1 INSR PTPRJ SDK1 TRIM46 VWA1 TIE1 IL2RG TNXB EPHA5 | 6.30e-06 | 199 | 190 | 11 | PS50853 |
| Domain | PROTEIN_KINASE_TYR | 6.61e-06 | 97 | 190 | 8 | PS00109 | |
| Domain | Tyr_kinase_AS | 6.61e-06 | 97 | 190 | 8 | IPR008266 | |
| Domain | CarboxyPept_regulatory_dom | 6.91e-06 | 13 | 190 | 4 | IPR014766 | |
| Domain | - | 6.91e-06 | 13 | 190 | 4 | 2.60.40.1120 | |
| Domain | FN3_dom | EPHB4 IGFN1 INSR PTPRJ SDK1 TRIM46 VWA1 TIE1 IL2RG TNXB EPHA5 | 1.00e-05 | 209 | 190 | 11 | IPR003961 |
| Domain | EGF_1 | LAMA1 F10 NRXN1 AREG CRB1 CELSR3 CELSR2 TENM3 TIE1 VCAN MUC4 TNXB | 1.23e-05 | 255 | 190 | 12 | PS00022 |
| Domain | ConA-like_dom | LAMA1 COL22A1 ADGRV1 CLC NRXN1 ALK TRIM46 CRB1 CELSR3 CELSR2 NPTXR | 1.56e-05 | 219 | 190 | 11 | IPR013320 |
| Domain | Laminin_G | 2.67e-05 | 58 | 190 | 6 | IPR001791 | |
| Domain | Tyr_kinase_cat_dom | 3.20e-05 | 88 | 190 | 7 | IPR020635 | |
| Domain | TyrKc | 3.20e-05 | 88 | 190 | 7 | SM00219 | |
| Domain | LAM_G_DOMAIN | 3.95e-05 | 38 | 190 | 5 | PS50025 | |
| Domain | Laminin_G_2 | 5.09e-05 | 40 | 190 | 5 | PF02210 | |
| Domain | Pkinase_Tyr | 5.28e-05 | 129 | 190 | 8 | PF07714 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 5.59e-05 | 8 | 190 | 3 | IPR019565 | |
| Domain | Carb-bd-like_fold | 5.59e-05 | 8 | 190 | 3 | IPR013784 | |
| Domain | Thiol-ester_cl | 5.59e-05 | 8 | 190 | 3 | PF10569 | |
| Domain | MacrogloblnA2_CS | 5.59e-05 | 8 | 190 | 3 | IPR019742 | |
| Domain | LamG | 8.14e-05 | 44 | 190 | 5 | SM00282 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 8.51e-05 | 138 | 190 | 8 | IPR001245 | |
| Domain | A2M | 1.18e-04 | 10 | 190 | 3 | PF00207 | |
| Domain | A2M_N_2 | 1.18e-04 | 10 | 190 | 3 | IPR011625 | |
| Domain | A2M_comp | 1.18e-04 | 10 | 190 | 3 | IPR011626 | |
| Domain | A2M_recep | 1.18e-04 | 10 | 190 | 3 | PF07677 | |
| Domain | A2M_comp | 1.18e-04 | 10 | 190 | 3 | PF07678 | |
| Domain | A2M_N | 1.18e-04 | 10 | 190 | 3 | PF01835 | |
| Domain | A2M_N | 1.18e-04 | 10 | 190 | 3 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.18e-04 | 10 | 190 | 3 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.18e-04 | 10 | 190 | 3 | PS00477 | |
| Domain | A2M_N_2 | 1.18e-04 | 10 | 190 | 3 | PF07703 | |
| Domain | Macroglobln_a2 | 1.18e-04 | 10 | 190 | 3 | IPR001599 | |
| Domain | Growth_fac_rcpt_ | 1.99e-04 | 156 | 190 | 8 | IPR009030 | |
| Domain | PROTEIN_KINASE_ATP | EPHB4 PDGFRB INSR DAPK1 JAK1 PASK ALK CDC42BPG PIM2 LRRK1 ERN2 AATK TIE1 EPHA5 | 2.64e-04 | 459 | 190 | 14 | PS00107 |
| Domain | SPAR_C | 3.07e-04 | 3 | 190 | 2 | PF11881 | |
| Domain | SIPA1L_C | 3.07e-04 | 3 | 190 | 2 | IPR021818 | |
| Domain | Kinase-like_dom | EPHB4 PDGFRB INSR WDR81 DAPK1 JAK1 PASK ALK CDC42BPG PIM2 LRRK1 ERN2 AATK TIE1 EPHA5 | 4.48e-04 | 542 | 190 | 15 | IPR011009 |
| Domain | Prot_kinase_dom | EPHB4 PDGFRB INSR DAPK1 JAK1 PASK ALK CDC42BPG PIM2 LRRK1 ERN2 AATK TIE1 EPHA5 | 4.98e-04 | 489 | 190 | 14 | IPR000719 |
| Domain | Protein_kinase_ATP_BS | EPHB4 PDGFRB INSR DAPK1 JAK1 PASK ALK CDC42BPG PIM2 AATK TIE1 EPHA5 | 5.22e-04 | 379 | 190 | 12 | IPR017441 |
| Domain | VWF_type-D | 5.26e-04 | 16 | 190 | 3 | IPR001846 | |
| Domain | VWFD | 5.26e-04 | 16 | 190 | 3 | PS51233 | |
| Domain | VWD | 5.26e-04 | 16 | 190 | 3 | SM00216 | |
| Domain | VWD | 5.26e-04 | 16 | 190 | 3 | PF00094 | |
| Domain | PROTEIN_KINASE_DOM | EPHB4 PDGFRB INSR DAPK1 JAK1 PASK ALK CDC42BPG PIM2 LRRK1 ERN2 AATK TIE1 EPHA5 | 5.39e-04 | 493 | 190 | 14 | PS50011 |
| Domain | ASX_HYDROXYL | 5.53e-04 | 100 | 190 | 6 | PS00010 | |
| Domain | RetinoicA-induced_16-like | 6.09e-04 | 4 | 190 | 2 | IPR019384 | |
| Domain | RAI16-like | 6.09e-04 | 4 | 190 | 2 | PF10257 | |
| Domain | SHR-BD | 6.09e-04 | 4 | 190 | 2 | IPR009543 | |
| Domain | ROC_dom | 6.09e-04 | 4 | 190 | 2 | IPR020859 | |
| Domain | ROC | 6.09e-04 | 4 | 190 | 2 | PS51424 | |
| Domain | VPS13_C | 6.09e-04 | 4 | 190 | 2 | PF16909 | |
| Domain | VPS13_C | 6.09e-04 | 4 | 190 | 2 | IPR031645 | |
| Domain | SHR-BD | 6.09e-04 | 4 | 190 | 2 | PF06650 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 7.53e-04 | 106 | 190 | 6 | IPR000152 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 7.56e-04 | 18 | 190 | 3 | IPR008930 | |
| Domain | Anaphylatoxin_comp_syst | 1.01e-03 | 5 | 190 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 1.01e-03 | 5 | 190 | 2 | IPR001840 | |
| Domain | Hydantoinase/dihydroPyrase | 1.50e-03 | 6 | 190 | 2 | IPR011778 | |
| Domain | WxxW_domain | 1.50e-03 | 6 | 190 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 1.50e-03 | 6 | 190 | 2 | PF13330 | |
| Domain | Ig-like_dom | IGFN1 PDGFRB SIGLEC8 HLA-E PXDN SDK1 LILRB5 SLAMF9 CILP TIGIT TIE1 VCAN BTN2A3P | 1.97e-03 | 503 | 190 | 13 | IPR007110 |
| Domain | ANATO | 2.09e-03 | 7 | 190 | 2 | SM00104 | |
| Domain | ANAPHYLATOXIN_2 | 2.09e-03 | 7 | 190 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 2.09e-03 | 7 | 190 | 2 | PS01177 | |
| Domain | ANATO | 2.09e-03 | 7 | 190 | 2 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 2.09e-03 | 7 | 190 | 2 | IPR000020 | |
| Domain | Chorein_N | 2.77e-03 | 8 | 190 | 2 | PF12624 | |
| Domain | VPS9 | 2.77e-03 | 8 | 190 | 2 | SM00167 | |
| Domain | Calx_beta | 2.77e-03 | 8 | 190 | 2 | SM00237 | |
| Domain | VPS13_N | 2.77e-03 | 8 | 190 | 2 | IPR026854 | |
| Domain | - | 2.77e-03 | 8 | 190 | 2 | 2.30.40.10 | |
| Domain | A2M_N_2 | 2.77e-03 | 8 | 190 | 2 | SM01359 | |
| Domain | - | 2.77e-03 | 8 | 190 | 2 | 2.60.40.690 | |
| Domain | A2M_recep | 2.77e-03 | 8 | 190 | 2 | SM01361 | |
| Domain | A2M | 2.77e-03 | 8 | 190 | 2 | SM01360 | |
| Pubmed | NCOA3 RPL27 PDE4B HDAC4 SIPA1L3 WDR81 DAPK1 EDC4 NRXN1 BSN TRIM46 DPYSL2 DPYSL4 GRIN2B CCDC88A PBRM1 AKAP9 CELSR2 SIPA1L1 DCHS1 UBA6 PARD3 CEP170B PHLDB2 | 9.56e-10 | 963 | 193 | 24 | 28671696 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RPL27 HIVEP2 HDAC4 SIPA1L3 KIF1B EDC4 CCSER2 ZNF286B FIP1L1 NR3C2 WDR62 SLC1A5 SYDE1 VPS13D CCDC88A AKAP9 SIPA1L1 EIF3I PARD3 CEP170B PHLDB2 OTOG | 3.21e-09 | 861 | 193 | 22 | 36931259 |
| Pubmed | Stromal complement receptor CD21/35 facilitates lymphoid prion colonization and pathogenesis. | 4.58e-09 | 5 | 193 | 4 | 17947689 | |
| Pubmed | 2.15e-08 | 83 | 193 | 8 | 11114734 | ||
| Pubmed | 1.68e-07 | 3 | 193 | 3 | 36011023 | ||
| Pubmed | 1.68e-07 | 3 | 193 | 3 | 11857338 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 1.68e-07 | 3 | 193 | 3 | 25576386 | |
| Pubmed | Large-scale structural analysis of the classical human protein tyrosine phosphatome. | 2.40e-07 | 47 | 193 | 6 | 19167335 | |
| Pubmed | 6.70e-07 | 4 | 193 | 3 | 11067882 | ||
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 6.70e-07 | 4 | 193 | 3 | 31833031 | |
| Pubmed | 6.70e-07 | 4 | 193 | 3 | 9267806 | ||
| Pubmed | 6.70e-07 | 4 | 193 | 3 | 15477230 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPHB4 TBC1D9B HIVEP2 ZNF585A KIF26A SIPA1L3 IPP EDC4 KDM6B FHIP1B PLEKHM1 DVL1 LRRK1 SLC1A5 MXD4 ZNF503 HIVEP3 AATK CELSR3 CELSR2 CEP170B | 1.03e-06 | 1105 | 193 | 21 | 35748872 |
| Pubmed | 1.64e-06 | 36 | 193 | 5 | 22421546 | ||
| Pubmed | 1.67e-06 | 5 | 193 | 3 | 15192652 | ||
| Pubmed | Protective T cell-independent antiviral antibody responses are dependent on complement. | 1.67e-06 | 5 | 193 | 3 | 10523614 | |
| Pubmed | SIPA1L3 EDC4 PASK WDR62 SNX29 VPS13D CCDC88A SIPA1L1 CEP170B | 2.81e-06 | 209 | 193 | 9 | 36779422 | |
| Pubmed | Androgen-dependent hereditary mouse keratoconus: linkage to an MHC region. | 3.32e-06 | 6 | 193 | 3 | 11773012 | |
| Pubmed | 3.32e-06 | 6 | 193 | 3 | 19710450 | ||
| Pubmed | 3.32e-06 | 6 | 193 | 3 | 34989544 | ||
| Pubmed | A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice. | 3.34e-06 | 19 | 193 | 4 | 11707574 | |
| Pubmed | 5.11e-06 | 21 | 193 | 4 | 8138038 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 12783862 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 10374907 | ||
| Pubmed | Recombination in the class III region of the mouse major histocompatibility complex. | 6.22e-06 | 22 | 193 | 4 | 7916002 | |
| Pubmed | 8.63e-06 | 130 | 193 | 7 | 12421765 | ||
| Pubmed | Divergent immunoglobulin g subclass activity through selective Fc receptor binding. | 9.23e-06 | 8 | 193 | 3 | 16322460 | |
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 9.23e-06 | 8 | 193 | 3 | 15257293 | |
| Pubmed | Molecular genetics of the human MHC complement gene cluster. | 9.23e-06 | 8 | 193 | 3 | 10072631 | |
| Pubmed | 1.38e-05 | 9 | 193 | 3 | 1373139 | ||
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 1.38e-05 | 9 | 193 | 3 | 36261522 | |
| Pubmed | 1.49e-05 | 257 | 193 | 9 | 16335952 | ||
| Pubmed | KIF1B PEG3 FHIP1B PXDN NAV3 FHIP2A AKAP9 TENM3 SIPA1L1 VPS13B CEP170B | 1.91e-05 | 407 | 193 | 11 | 12693553 | |
| Pubmed | RPL27 EDC4 NRXN1 KCND2 FRRS1L NAV3 SPARCL1 BSN DPYSL2 DVL1 TACC2 CPZ GRIN2B CCDC88A CELSR2 SIPA1L1 EIF3I CEP170B PRNP | 2.15e-05 | 1139 | 193 | 19 | 36417873 | |
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 2.69e-05 | 11 | 193 | 3 | 32820719 | |
| Pubmed | Organizations and gene duplications of the human and mouse MHC complement gene clusters. | 2.69e-05 | 11 | 193 | 3 | 10686478 | |
| Pubmed | WDFY4 is required for cross-presentation in response to viral and tumor antigens. | 2.82e-05 | 156 | 193 | 7 | 30409884 | |
| Pubmed | 2.92e-05 | 64 | 193 | 5 | 22261194 | ||
| Pubmed | EPHB4 RPL27 PDE7A PASK NOMO2 CCSER2 ASCC2 TTC13 PLRG1 CLUH WDR62 TBC1D15 TARS2 SLC1A5 SNX29 NOMO1 CCDC88A TBC1D31 AKAP9 UBA6 PARD3 VPS13B | 2.96e-05 | 1487 | 193 | 22 | 33957083 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CPAMD8 HIVEP2 HDAC4 SIPA1L3 KIF1B INSR ADGRV1 SESN1 PLEKHM1 PXDN PTPRJ CDC42BPG DPYSL2 DTNB MAN1C1 TARS2 SNX29 HIVEP3 UBA6 PARD3 VPS13B CEP170B | 3.02e-05 | 1489 | 193 | 22 | 28611215 |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 19062096 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 10222050 | ||
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 3.06e-05 | 2 | 193 | 2 | 17645767 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 12207352 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 3.06e-05 | 2 | 193 | 2 | 27758680 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 20360974 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 35264209 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 3.06e-05 | 2 | 193 | 2 | 3037333 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 11726230 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 4216347 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 28189690 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 3.06e-05 | 2 | 193 | 2 | 8428773 | |
| Pubmed | Proposed structural models of human factor Va and prothrombinase. | 3.06e-05 | 2 | 193 | 2 | 17973648 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 24638111 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 10790539 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 20404140 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 3.06e-05 | 2 | 193 | 2 | 21345967 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 2302180 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 23002439 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 22151770 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 29080553 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 3.06e-05 | 2 | 193 | 2 | 25339671 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 17263731 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 17728371 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 6149580 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 6149581 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 3542363 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 2387317 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 37095322 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 36502323 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 7365238 | ||
| Pubmed | DPYSL2 interacts with JAK1 to mediate breast cancer cell migration. | 3.06e-05 | 2 | 193 | 2 | 35575798 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 17971360 | ||
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 3.06e-05 | 2 | 193 | 2 | 17971229 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 15319348 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 26364583 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 35898513 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 28873507 | ||
| Pubmed | Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. | 3.06e-05 | 2 | 193 | 2 | 3052293 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 3794341 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 22785613 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 18591887 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 32691186 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 20722419 | ||
| Pubmed | The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter. | 3.06e-05 | 2 | 193 | 2 | 8390682 | |
| Pubmed | Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp). | 3.06e-05 | 2 | 193 | 2 | 3902619 | |
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 3.06e-05 | 2 | 193 | 2 | 7373044 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 3.06e-05 | 2 | 193 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 3.06e-05 | 2 | 193 | 2 | 16098595 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 3.06e-05 | 2 | 193 | 2 | 15787745 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 30026462 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 6559257 | ||
| Pubmed | PDGFRβ reverses EphB4 signaling in alveolar rhabdomyosarcoma. | 3.06e-05 | 2 | 193 | 2 | 24733895 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 21071689 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 12480675 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 26800705 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 11094166 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 28858643 | ||
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 3.06e-05 | 2 | 193 | 2 | 1699796 | |
| Pubmed | Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp. | 3.06e-05 | 2 | 193 | 2 | 2997024 | |
| Interaction | FBXO2 interactions | EPHB4 INSR LAMA1 EMILIN3 ADGRV1 PXDN PTPRJ TTC13 NOMO1 CEMIP CELSR3 TENM3 NPTXR NOMO3 PRNP EPHA5 | 1.90e-06 | 411 | 190 | 16 | int:FBXO2 |
| Interaction | IL5RA interactions | 2.72e-06 | 124 | 190 | 9 | int:IL5RA | |
| Interaction | AFDN interactions | SIPA1L3 NRXN1 SDK1 HORMAD2 BIRC3 SLC1A5 SYDE1 RIN1 CCDC88A SIPA1L1 PARD3 PRNP PHLDB2 | 1.75e-05 | 333 | 190 | 13 | int:AFDN |
| Interaction | VPS33B interactions | KIF1B CCSER2 DPYSL2 LYG2 SNX29 CCDC88A TBC1D31 SIPA1L1 CEP170B PHLDB2 | 2.00e-05 | 199 | 190 | 10 | int:VPS33B |
| GeneFamily | Fibronectin type III domain containing | 3.16e-07 | 160 | 134 | 10 | 555 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 1.11e-05 | 40 | 134 | 5 | 321 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 3.24e-05 | 9 | 134 | 3 | 1234 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 1.58e-04 | 37 | 134 | 4 | 454 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 1.63e-04 | 3 | 134 | 2 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 1.63e-04 | 3 | 134 | 2 | 1189 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 8.72e-04 | 206 | 134 | 7 | 682 | |
| GeneFamily | SH2 domain containing|Suppressors of cytokine signaling | 1.48e-03 | 8 | 134 | 2 | 764 | |
| GeneFamily | VPS9 domain containing | 2.36e-03 | 10 | 134 | 2 | 928 | |
| GeneFamily | Complement system|Sushi domain containing | 2.38e-03 | 36 | 134 | 3 | 492 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.70e-03 | 394 | 134 | 9 | 471 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 4.68e-03 | 14 | 134 | 2 | 1095 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | NCOA3 RPL27 PDE4B HIVEP2 PDE7A PHF19 HLA-E PSMB8 ZNF831 ZC3H6 CISH JAK1 PTPRJ CCSER2 PIM2 MAN1C1 BIRC3 FHIP2A MXD4 HIVEP3 CCDC88A AKAP9 TIGIT NFATC2IP CD44 IL2RG CTSS VPS13B PRNP | 1.34e-06 | 1492 | 191 | 29 | M40023 |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | EPS8 PEG3 SESN1 CISH SOCS2 JAK1 PXDN KCND2 PHLPP1 CR2 RCAN3 ZNF503 CELSR3 TENM3 TIE1 NPTXR MUC4 PHLDB2 EPHA5 | 1.52e-06 | 721 | 191 | 19 | M1999 |
| Coexpression | NABA_MATRISOME | ADAMTS19 CPAMD8 INHA LAMA1 EMILIN3 COL22A1 HRNR F10 CLC PXDN SPARCL1 CILP VWA1 FREM3 AREG ANGPTL6 INSL6 VCAN MUC4 TNXB CTSS OTOG | 6.30e-06 | 1026 | 191 | 22 | M5889 |
| Coexpression | AIZARANI_LIVER_C28_NK_NKT_CELLS_6 | 8.26e-06 | 99 | 191 | 7 | M39127 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_DN | 1.64e-05 | 199 | 191 | 9 | M4407 | |
| Coexpression | PEREZ_TP53_TARGETS | KIF26A ABCA13 KIF1B INSR IPP EMILIN3 COL22A1 ADGRV1 PTPRJ C4A MN1 CILP MAN1C1 DPYSL4 VWA1 CEMIP TBC1D31 AKAP9 CELSR2 VCAN DISP1 VPS13B CEP170B | 2.34e-05 | 1201 | 191 | 23 | M4391 |
| Coexpression | NABA_CORE_MATRISOME | 3.12e-05 | 270 | 191 | 10 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 3.64e-05 | 275 | 191 | 10 | M5884 | |
| Coexpression | NABA_MATRISOME | ADAMTS19 INHA LAMA1 EMILIN3 COL22A1 HRNR F10 PXDN SPARCL1 CILP VWA1 FREM3 AREG ANGPTL6 INSL6 VCAN MUC4 TNXB CTSS OTOG | 5.08e-05 | 1008 | 191 | 20 | MM17056 |
| Coexpression | LEE_BMP2_TARGETS_UP | EPS8 HLA-E PSMB8 DAPK1 F5 SESN1 KCND2 CILP CPZ LRRK1 MXD4 PLPP6 TIE1 DCHS1 RBM24 TNXB VPS13B | 6.17e-05 | 780 | 191 | 17 | M2324 |
| Coexpression | FORTSCHEGGER_PHF8_TARGETS_DN | IGFN1 HIVEP2 HDAC4 POLR3H KIF1B PLEKHM1 CCSER2 DPYSL2 PLEKHG4 BIRC3 TACC2 SNX29 ST6GALNAC2 TENT5B TNXB CTSS PHLDB2 | 6.46e-05 | 783 | 191 | 17 | M2488 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 8.35e-05 | 191 | 191 | 8 | MM17059 | |
| Coexpression | LEE_BMP2_TARGETS_UP | EPS8 HLA-E PSMB8 DAPK1 F5 SESN1 KCND2 CILP CPZ LRRK1 MXD4 PLPP6 TIE1 DCHS1 RBM24 TNXB VPS13B | 9.04e-05 | 805 | 191 | 17 | MM1067 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN | PEG3 DAPK1 PARP4 PXDN MN1 SDK1 ALK MAN1C1 FHIP2A TENM3 SIPA1L1 PHLDB2 | 9.58e-05 | 438 | 191 | 12 | M227 |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP | RPL27 PDE7A PDGFRB PEG3 LIN9 PASK FRRS1L ZNF286B PIP5K1B SDK1 TRIM46 TBX4 SLC1A5 CCDC88A CELSR3 NPTXR VCAN BTN2A3P | 9.79e-05 | 891 | 191 | 18 | M45033 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.00e-04 | 196 | 191 | 8 | M3008 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP | 1.00e-04 | 196 | 191 | 8 | M5381 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_MONOCYTE_AGEING | 1.05e-04 | 147 | 191 | 7 | MM3707 | |
| Coexpression | DESCARTES_FETAL_HEART_STROMAL_CELLS | 1.07e-04 | 34 | 191 | 4 | M40199 | |
| Coexpression | GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_UP | 1.11e-04 | 199 | 191 | 8 | M5978 | |
| Coexpression | GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_DN | 1.11e-04 | 199 | 191 | 8 | M8391 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN | 1.11e-04 | 199 | 191 | 8 | M3440 | |
| Coexpression | GSE7831_1H_VS_4H_CPG_STIM_PDC_DN | 1.11e-04 | 199 | 191 | 8 | M6961 | |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP | 1.15e-04 | 200 | 191 | 8 | M9313 | |
| Coexpression | GSE3982_BASOPHIL_VS_TH2_UP | 1.15e-04 | 200 | 191 | 8 | M5566 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | 1.50e-04 | 265 | 191 | 9 | M1684 | |
| Coexpression | UNTERMAN_IPF_VS_CTRL_TREG_CELL_UP | 1.62e-04 | 15 | 191 | 3 | M48289 | |
| Coexpression | GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_UP | 1.78e-04 | 160 | 191 | 7 | M8183 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | 1.82e-04 | 272 | 191 | 9 | MM1027 | |
| Coexpression | MARTENS_TRETINOIN_RESPONSE_UP | SIGLEC8 EMILIN3 TMEM130 PXDN KCNK15 TPSG1 MN1 LILRB5 TRIM46 CILP DPYSL4 CPZ MXD4 CELSR2 MUC4 CEP170B OTOG | 1.85e-04 | 855 | 191 | 17 | M2098 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA3 EPS8 HIVEP2 HDAC4 DAPK1 NFKB1 CCSER2 NAV3 PHLPP1 MN1 SFMBT1 CEMIP TBC1D31 AKAP9 SIPA1L1 PARD3 VPS13B | 1.88e-04 | 856 | 191 | 17 | M4500 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 2.03e-04 | 276 | 191 | 9 | M3063 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | PDGFRB KIF26A SIPA1L3 KIF1B INSR EMILIN3 KDM6B JAK1 TMEM130 HOXD13 ALK SFMBT1 TBX4 PNLIPRP1 DPYSL4 AKAP9 CELSR3 SIPA1L1 VCAN VPS13B EPHA5 | 1.36e-05 | 818 | 189 | 21 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 ABCA13 LAMA1 COL22A1 ADGRV1 NRXN1 NAV3 SDK1 GRIN2B OTOG EPHA5 | 5.39e-10 | 184 | 193 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 ABCA13 LAMA1 COL22A1 ADGRV1 NRXN1 NAV3 SDK1 GRIN2B OTOG EPHA5 | 5.39e-10 | 184 | 193 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 ABCA13 LAMA1 COL22A1 ADGRV1 NRXN1 NAV3 SDK1 GRIN2B OTOG EPHA5 | 5.39e-10 | 184 | 193 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | SIPA1L3 ADGRV1 PTPRJ PIP5K1B NR3C2 SDK1 HIVEP3 SIPA1L1 PARD3 VPS13B | 1.53e-08 | 196 | 193 | 10 | ab53c742866945545a92e2e61850d63c80d9a2a6 |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.71e-08 | 161 | 193 | 9 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-07 | 181 | 193 | 9 | dae0d106f0eee5dba538617f8ed724925ea35f17 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.02e-07 | 181 | 193 | 9 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | VE-Treg-CD4_Treg|VE / Condition, Cell_class and T cell subcluster | 1.40e-07 | 188 | 193 | 9 | fa88ceb336e30de3585e62608527a0d44df74190 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.40e-07 | 188 | 193 | 9 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-07 | 189 | 193 | 9 | 1cfc1fe27c4b57b4e52700fa8f679ce172cee5a9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-07 | 194 | 193 | 9 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.83e-07 | 194 | 193 | 9 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.91e-07 | 195 | 193 | 9 | 7b181e5b05becec3fd5031849affa9a135b26d3f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.00e-07 | 196 | 193 | 9 | 9a28571e01d020e2ebe77690619182f4e4ffe696 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.00e-07 | 196 | 193 | 9 | ab6022041c33617bca3ed0c62f19673cd2750da9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.00e-07 | 196 | 193 | 9 | 157e98bd079e0217c3380e245775794c5ba5c8bd | |
| ToppCell | CV-Severe-0|Severe / Virus stimulation, Condition and Cluster | 2.09e-07 | 197 | 193 | 9 | d13fc20b31ab6d9117437fba319c72f3a552858f | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.18e-07 | 198 | 193 | 9 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | severe-Treg|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.18e-07 | 198 | 193 | 9 | 377980b9f7d02818e1d145e6884604f8bfacc4f2 | |
| ToppCell | severe-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.18e-07 | 198 | 193 | 9 | 4935b40fc848037a06055f30d90bde940b9d5321 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.37e-07 | 200 | 193 | 9 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | BL-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.57e-07 | 162 | 193 | 8 | 25ec9df914445b4daae4fd28fd0e60b64797c46d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.01e-07 | 167 | 193 | 8 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.34e-07 | 168 | 193 | 8 | 948d9e9972bd2a4b503d55fa69b70dd568a35a67 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.02e-07 | 170 | 193 | 8 | a6fa0cab1fa829ec601fe48306b4c43c83425b04 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.02e-07 | 170 | 193 | 8 | b40255eee45eb18b5a297336d7f3845fd8f8aa3b | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-06 | 178 | 193 | 8 | 07d6d5275a4d17f8024fde74e92ab2505b4adfbf | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-06 | 181 | 193 | 8 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-06 | 182 | 193 | 8 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_T-T_NK-CD8_T_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.34e-06 | 182 | 193 | 8 | 98c26ad34e01c4b8997d26d5d28a9935491295fa | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-06 | 184 | 193 | 8 | d1ea2b60fb1ca1a0b809d131310c43903a9e84ce | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-Treg|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.51e-06 | 185 | 193 | 8 | a86a3a1a187a4d8d7762bc6d3dcb22c982178d22 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 1.51e-06 | 185 | 193 | 8 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | facs-Large_Intestine-Distal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 185 | 193 | 8 | 7a18d525de6f874924bfc61b9666b307da86421a | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 185 | 193 | 8 | e29079ef09aee62c3e9756341db4e59ca9dbf7ac | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 185 | 193 | 8 | fd1911b57927c03470f9387962ca9581e5643fb3 | |
| ToppCell | LPS_only|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-06 | 185 | 193 | 8 | a72ccb147ca505880e2da8f6a70b9d570464a691 | |
| ToppCell | facs-Large_Intestine-Distal-24m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 185 | 193 | 8 | 2ecc4b76b3645b65c226c2298bff307cc6479172 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-06 | 188 | 193 | 8 | bba6b273bd47dd0e27fde914e9e6fc9d76fd5176 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.71e-06 | 188 | 193 | 8 | 939790f133eac9c12d08db6ddb5f08f5107844e3 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 188 | 193 | 8 | 8cc927b4c51d982fdafa04dc7393617ad9bb220e | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-SELL+_CD4_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.78e-06 | 189 | 193 | 8 | 5c92516c3745ccbd480b15bb2b9077ab1d9ee5a0 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-06 | 189 | 193 | 8 | 6c71e81373cb7822de23c193a6350b6df9f567bc | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.80e-06 | 132 | 193 | 7 | 893b7ec2a2d8a140cc98575d1beca1189f053e9a | |
| ToppCell | facs-Large_Intestine-Distal|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 190 | 193 | 8 | 3964a8390522b61b73235151bb0a2ff36b856867 | |
| ToppCell | COVID-19_Severe-Treg|COVID-19_Severe / Disease condition and Cell class | 1.92e-06 | 191 | 193 | 8 | 06fdd76ea13b93e29959c745698b57af6746aaeb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-06 | 191 | 193 | 8 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 1.92e-06 | 191 | 193 | 8 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | Control-Treg|Control / Disease group and Cell class | 2.00e-06 | 192 | 193 | 8 | 3a9a8ac2aa278adde848608f9bb92a002dbb9bcc | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-06 | 192 | 193 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.00e-06 | 192 | 193 | 8 | 7ab626a516b07d899175ff12f1c8257688324e4b | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.00e-06 | 192 | 193 | 8 | 011634a24b0c61d9b463fe755502edbc5cd70b7a | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-Treg|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.00e-06 | 192 | 193 | 8 | 0deb6aa323e1de72ee8a2002449e523dd4f0bf5d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-06 | 194 | 193 | 8 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.16e-06 | 194 | 193 | 8 | 5594f7437448cb4b37d2d100f44d30c4a367df26 | |
| ToppCell | Control-Treg|Control / Disease condition and Cell class | 2.24e-06 | 195 | 193 | 8 | bbe9789eb2c17f43de55b2e6d01d1093c64dc666 | |
| ToppCell | 3'-Pediatric_IBD|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.24e-06 | 195 | 193 | 8 | 728776511e1f40f127f80ef1eecda6d6ad082392 | |
| ToppCell | (05)_Secretory|World / shred by cell type by condition | 2.33e-06 | 196 | 193 | 8 | 8032c25b51ef96aeba28cc52686a2bd45213453d | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.42e-06 | 197 | 193 | 8 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | BAL-Control-cDC_5|Control / Compartment, Disease Groups and Clusters | 2.42e-06 | 197 | 193 | 8 | 8a3fe59be3ed1f0254cc8c60b99c840193370efb | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.42e-06 | 197 | 193 | 8 | 0c059476a8cdc6ac71a01d9c414295177f45f8de | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 2.42e-06 | 197 | 193 | 8 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 2.42e-06 | 197 | 193 | 8 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | T_cells-CCR7+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.61e-06 | 199 | 193 | 8 | 467820d6abe3024d9d655b9672c2f9cdc1303db3 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-06 | 199 | 193 | 8 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.61e-06 | 199 | 193 | 8 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.61e-06 | 199 | 193 | 8 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-Adventitial_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.61e-06 | 199 | 193 | 8 | ab0589c068c24aa989bdca083504fbad0c15221d | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.61e-06 | 199 | 193 | 8 | da20998253ad08a4a127a98b991b26237edb61a2 | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.61e-06 | 199 | 193 | 8 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-06 | 200 | 193 | 8 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-06 | 200 | 193 | 8 | b1be27d134a8633e3e7862c6a0d7be2001d387f0 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-06 | 200 | 193 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-06 | 200 | 193 | 8 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-06 | 200 | 193 | 8 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-Treg|COVID-19_Severe / Disease, condition lineage and cell class | 2.71e-06 | 200 | 193 | 8 | 2b363f2a1d08019b6ff0b10419870049063cc1cf | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-06 | 200 | 193 | 8 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-06 | 142 | 193 | 7 | 6469cf82552b39f63e20b841c9eed50de6f58d54 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-06 | 145 | 193 | 7 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | MS-CD4-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster | 4.59e-06 | 152 | 193 | 7 | b1eba2d5a6da3eeb83d40a92976e3e8751ed18ee | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Myeloid-macrophage|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-06 | 153 | 193 | 7 | 4b999892fb797e9f0d391630094f466463299d57 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Myeloid-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-06 | 153 | 193 | 7 | e426db29e4ba83e7930dc88c74fc975b177c9540 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Myeloid|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-06 | 153 | 193 | 7 | 668eacd76aad6054bd7d57e3af0b122c2443465f | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 5.68e-06 | 157 | 193 | 7 | 23879e65a6acc33d9aad096cd23604a77b0ac9c2 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.17e-06 | 104 | 193 | 6 | 424a58b04c8b5108b70f15d8353c8e4b9db1e730 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.17e-06 | 104 | 193 | 6 | 11d91471b6c4fa6b00a91d9fd4db72ee60d1f801 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.17e-06 | 104 | 193 | 6 | 9b05ae514437eb0c8b1b23607ae8cbc371ffa85b | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-06 | 160 | 193 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-06 | 160 | 193 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.97e-06 | 162 | 193 | 7 | ee6f05620f4f4ebbebd5b098afc7c20876e3d21f | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.97e-06 | 162 | 193 | 7 | 9e72d468fcdd0d27b517a9e36efb35d4617a88f9 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.86e-06 | 165 | 193 | 7 | 570483b43ccb5831feec9337b4664814431d40b1 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue | 7.86e-06 | 165 | 193 | 7 | 7b992843bd8ef92a7a76b1d681fa84efde6f5bdd | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.86e-06 | 165 | 193 | 7 | 1c630f9ecde2e0243922a2be4b1ab5adcfcb0893 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.86e-06 | 165 | 193 | 7 | 2026a9a07f4d314cc05c167e491312b373468e46 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.18e-06 | 166 | 193 | 7 | f742d15b02a6f651bbd00f53e3d871f40d05a03d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.18e-06 | 166 | 193 | 7 | 0f013bb5fdb72e88c2fc73d60cd01551a2db6341 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.18e-06 | 166 | 193 | 7 | e941df9a1091164edde3def8fc7d410186b2bd88 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.18e-06 | 166 | 193 | 7 | 1a3a15d1fc76bb91d832cdc6e3da0a6140b94b75 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.18e-06 | 166 | 193 | 7 | aeda46bea5d8463c24a83b98b9ed92d962d733e5 | |
| Drug | 5 alpha-dihydroaldosterone | 5.90e-07 | 3 | 192 | 3 | CID003036614 | |
| Drug | clozapine; Up 200; 10uM; HL60; HT_HG-U133A | 7.08e-06 | 197 | 192 | 10 | 2689_UP | |
| Drug | LY294002; Up 200; 10uM; PC3; HG-U133A | HIVEP2 INPP5K DAPK1 CCSER2 NR3C2 MN1 CILP MAN1C1 AKAP9 VPS13B | 7.40e-06 | 198 | 192 | 10 | 461_UP |
| Drug | Conessine [546-06-5]; Down 200; 11.2uM; HL60; HT_HG-U133A | EPHB4 HIVEP2 PASK PIP5K1B ERN2 MXD4 HIVEP3 CELSR3 CELSR2 CTSS | 7.74e-06 | 199 | 192 | 10 | 2135_DN |
| Drug | alpha-Santonin [481-06-1]; Down 200; 16.2uM; PC3; HT_HG-U133A | SIPA1L3 KDM6B SUPT7L PIM2 ERN2 SYDE1 RIN1 AATK PARD3 CEP170B | 7.74e-06 | 199 | 192 | 10 | 4531_DN |
| Drug | Brn 5233018 | 8.44e-06 | 57 | 192 | 6 | CID000128395 | |
| Disease | creatinine measurement | ABO PDE7A SIPA1L3 ADGRV1 PTPRJ NFKB1 FIP1L1 PIP5K1B BSN TRIM46 SFMBT1 TBX4 AREG CEMIP CELSR3 CELSR2 AP3B2 PARD3 CTSS | 2.03e-05 | 995 | 187 | 19 | EFO_0004518 |
| Disease | BRACHYDACTYLY, TYPE E1 | 4.00e-05 | 2 | 187 | 2 | C1862102 | |
| Disease | ulcerative colitis | EPHB4 PSMB8 ZNF831 NFKB1 BSN SFMBT1 HORMAD2 CELSR3 INSL6 TNXB | 5.97e-05 | 335 | 187 | 10 | EFO_0000729 |
| Disease | venous thromboembolism, factor VII measurement | 9.74e-05 | 38 | 187 | 4 | EFO_0004286, EFO_0004619 | |
| Disease | Neuroblastoma | 1.19e-04 | 3 | 187 | 2 | cv:C0027819 | |
| Disease | invasive ductal carcinoma (is_marker_for) | 1.19e-04 | 40 | 187 | 4 | DOID:3008 (is_marker_for) | |
| Disease | Leukemia, Myelocytic, Acute | 1.23e-04 | 173 | 187 | 7 | C0023467 | |
| Disease | interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement | 1.32e-04 | 16 | 187 | 3 | EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293 | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian serous carcinoma | 1.45e-04 | 42 | 187 | 4 | EFO_0004920, EFO_1001516, GO_0097328, MONDO_0009354 | |
| Disease | Acute Myeloid Leukemia, M1 | 1.50e-04 | 125 | 187 | 6 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 1.50e-04 | 125 | 187 | 6 | C1879321 | |
| Disease | Mental Depression | 2.29e-04 | 254 | 187 | 8 | C0011570 | |
| Disease | Hypereosinophilic syndrome | 2.38e-04 | 4 | 187 | 2 | C1540912 | |
| Disease | Chromosome 2q37 deletion syndrome | 2.38e-04 | 4 | 187 | 2 | C2931817 | |
| Disease | Profound Mental Retardation | 2.67e-04 | 139 | 187 | 6 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.67e-04 | 139 | 187 | 6 | C0025363 | |
| Disease | Mental deficiency | 2.67e-04 | 139 | 187 | 6 | C0917816 | |
| Disease | breast cancer, COVID-19 | 3.53e-04 | 22 | 187 | 3 | MONDO_0007254, MONDO_0100096 | |
| Disease | Anterior segment mesenchymal dysgenesis | 3.95e-04 | 5 | 187 | 2 | C1862839 | |
| Disease | gastroesophageal reflux disease | 4.69e-04 | 101 | 187 | 5 | EFO_0003948 | |
| Disease | Depressive disorder | 5.41e-04 | 289 | 187 | 8 | C0011581 | |
| Disease | creatine kinase measurement | 5.42e-04 | 59 | 187 | 4 | EFO_0004534 | |
| Disease | uric acid measurement | SIPA1L3 INSR ADGRV1 F5 NFKB1 PIP5K1B TRIM46 SFMBT1 CDC42BPG AREG CRB1 CEMIP | 5.50e-04 | 610 | 187 | 12 | EFO_0004761 |
| Disease | L lactate dehydrogenase measurement | 5.85e-04 | 26 | 187 | 3 | EFO_0004808 | |
| Disease | inflammatory biomarker measurement | 5.85e-04 | 26 | 187 | 3 | EFO_0004872 | |
| Disease | Central hypotonia | 5.89e-04 | 6 | 187 | 2 | C1842364 | |
| Disease | Intellectual Disability | HIVEP2 HDAC4 PDGFRB LAMA1 KDM6B NRXN1 MN1 WDR62 GRIN2B FHIP2A | 6.02e-04 | 447 | 187 | 10 | C3714756 |
| Disease | disease progression measurement | 6.15e-04 | 61 | 187 | 4 | EFO_0008336 | |
| Disease | peripheral vascular disease | 8.22e-04 | 7 | 187 | 2 | EFO_0003875 | |
| Disease | tumor necrosis factor ligand superfamily member 6, soluble form measurement | 8.22e-04 | 7 | 187 | 2 | EFO_0020797 | |
| Disease | D dimer measurement | 8.97e-04 | 30 | 187 | 3 | EFO_0004507 | |
| Disease | factor XI measurement, venous thromboembolism | 8.97e-04 | 30 | 187 | 3 | EFO_0004286, EFO_0004694 | |
| Disease | basophil count, eosinophil count | 9.07e-04 | 241 | 187 | 7 | EFO_0004842, EFO_0005090 | |
| Disease | renal cell carcinoma (is_implicated_in) | 9.79e-04 | 69 | 187 | 4 | DOID:4450 (is_implicated_in) | |
| Disease | chemokine (C-C motif) ligand 27 measurement | 1.03e-03 | 70 | 187 | 4 | EFO_0008082 | |
| Disease | microcephaly (implicated_via_orthology) | 1.09e-03 | 32 | 187 | 3 | DOID:10907 (implicated_via_orthology) | |
| Disease | stanniocalcin-1 measurement | 1.09e-03 | 8 | 187 | 2 | EFO_0020753 | |
| Disease | Anterior segment dysgenesis | 1.09e-03 | 8 | 187 | 2 | cv:C1862839 | |
| Disease | kidney disease | 1.09e-03 | 8 | 187 | 2 | EFO_0003086 | |
| Disease | visual acuity measurement | 1.09e-03 | 8 | 187 | 2 | EFO_0008385 | |
| Disease | cystatin C measurement | 1.12e-03 | 402 | 187 | 9 | EFO_0004617 | |
| Disease | eosinophil count | ADAMTS19 HIVEP2 ZNF585A ABO SIPA1L3 KDM6B SESN1 ZNF585B CISH JAK1 CLC PXDN PTPRJ NFKB1 ERN2 HIVEP3 PBRM1 AKAP9 BTN2A3P TNXB | 1.27e-03 | 1488 | 187 | 20 | EFO_0004842 |
| Disease | parental longevity | PDE4B COL22A1 CCSER2 PHLPP1 BSN HORMAD2 GRIN2B SNX29 CEMIP CELSR2 | 1.28e-03 | 494 | 187 | 10 | EFO_0007796 |
| Disease | factor VIII measurement, venous thromboembolism | 1.30e-03 | 34 | 187 | 3 | EFO_0004286, EFO_0004630 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.30e-03 | 34 | 187 | 3 | EFO_0008317, EFO_0008596, EFO_0020944 | |
| Disease | amino acid measurement | ADAMTS19 HDAC4 PASK PXDN PTPRJ NAV3 NR3C2 ALK TACC2 GRIN2B LRRK1 VCAN | 1.37e-03 | 678 | 187 | 12 | EFO_0005134 |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.37e-03 | 128 | 187 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.37e-03 | 128 | 187 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.37e-03 | 128 | 187 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 1.37e-03 | 128 | 187 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 1.37e-03 | 128 | 187 | 5 | C0007134 | |
| Disease | renal cell carcinoma (is_marker_for) | 1.37e-03 | 128 | 187 | 5 | DOID:4450 (is_marker_for) | |
| Disease | Abnormality of the face | 1.40e-03 | 9 | 187 | 2 | C4025871 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 1.40e-03 | 9 | 187 | 2 | EFO_0600040 | |
| Disease | tonsillectomy risk measurement | 1.41e-03 | 260 | 187 | 7 | EFO_0007924 | |
| Disease | Schizophrenia | PDE4B HDAC4 PDGFRB ABCA13 LAMA1 HLA-E SOCS2 NRXN1 DGCR8 ALK GRIN2B PBRM1 IL2RG TNXB | 1.57e-03 | 883 | 187 | 14 | C0036341 |
| Disease | cataract (implicated_via_orthology) | 1.79e-03 | 38 | 187 | 3 | DOID:83 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | CPAMD8 ABCA13 PEG3 LAMA1 IPP F5 NR3C2 DPYSL2 AKAP3 HIVEP3 AKAP9 DCHS1 | 1.82e-03 | 702 | 187 | 12 | C0009402 |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian carcinoma | 1.94e-03 | 39 | 187 | 3 | EFO_0001075, EFO_0004920, GO_0097328, MONDO_0009354 | |
| Disease | cervical cancer | 2.08e-03 | 40 | 187 | 3 | MONDO_0002974 | |
| Disease | Retinal Detachment | 2.12e-03 | 11 | 187 | 2 | C0035305 | |
| Disease | ovarian carcinoma, COVID-19 | 2.12e-03 | 11 | 187 | 2 | EFO_0001075, MONDO_0100096 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 2.12e-03 | 11 | 187 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | Immunoglobulin Deficiency, Late-Onset | 2.12e-03 | 11 | 187 | 2 | C2936665 | |
| Disease | Acquired Hypogammaglobulinemia | 2.12e-03 | 11 | 187 | 2 | C2936664 | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 2.12e-03 | 11 | 187 | 2 | DOID:9279 (implicated_via_orthology) | |
| Disease | glycerophosphorylcholine measurement | 2.12e-03 | 11 | 187 | 2 | EFO_0020018 | |
| Disease | QT interval | 2.26e-03 | 534 | 187 | 10 | EFO_0004682 | |
| Disease | venous thromboembolism, von Willebrand factor measurement | 2.40e-03 | 42 | 187 | 3 | EFO_0004286, EFO_0004629 | |
| Disease | hemorrhoid | 2.51e-03 | 147 | 187 | 5 | EFO_0009552 | |
| Disease | intracranial aneurysm (is_implicated_in) | 2.53e-03 | 12 | 187 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | anxiety disorder, stress-related disorder | 2.53e-03 | 12 | 187 | 2 | EFO_0006788, EFO_0010098 | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 2.57e-03 | 43 | 187 | 3 | DOID:9074 (implicated_via_orthology) | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 2.58e-03 | 148 | 187 | 5 | C0279702 | |
| Disease | high grade glioma (implicated_via_orthology) | 2.74e-03 | 44 | 187 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | body weight | PDE4B HIVEP2 INSR ADGRV1 SOCS2 NRXN1 PTPRJ FRRS1L SFMBT1 TBX4 C16orf82 DPYSL4 MXD4 CRB1 AATK TBC1D31 LINC01556 | 2.86e-03 | 1261 | 187 | 17 | EFO_0004338 |
| Disease | Gastric Adenocarcinoma | 2.92e-03 | 45 | 187 | 3 | C0278701 | |
| Disease | Common variable immunodeficiency | 2.98e-03 | 13 | 187 | 2 | cv:C0009447 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 2.98e-03 | 13 | 187 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | Leber congenital amaurosis (implicated_via_orthology) | 2.98e-03 | 13 | 187 | 2 | DOID:14791 (implicated_via_orthology) | |
| Disease | X-19141 measurement | 2.98e-03 | 13 | 187 | 2 | EFO_0800799 | |
| Disease | tyrosine-protein kinase receptor Tie-1, soluble measurement | 2.98e-03 | 13 | 187 | 2 | EFO_0008312 | |
| Disease | CD209 antigen measurement | 3.46e-03 | 14 | 187 | 2 | EFO_0008077 | |
| Disease | Malignant tumor of colon | 3.51e-03 | 159 | 187 | 5 | C0007102 | |
| Disease | Malignant neoplasm of breast | EPHB4 ADAMTS19 NCOA3 TBC1D9B HDAC4 INPP5K ALK PNLIPRP1 NOA1 TACC2 AREG PBRM1 AKAP9 SIPA1L1 VPS13B | 3.62e-03 | 1074 | 187 | 15 | C0006142 |
| Disease | hair color | 3.82e-03 | 311 | 187 | 7 | EFO_0003924 | |
| Disease | neurotic disorder | 3.95e-03 | 101 | 187 | 4 | EFO_0004257 | |
| Disease | BMI-adjusted adiponectin measurement | 3.97e-03 | 15 | 187 | 2 | EFO_0007737 | |
| Disease | Common Variable Immunodeficiency | 3.97e-03 | 15 | 187 | 2 | C0009447 | |
| Disease | suntan | 4.24e-03 | 103 | 187 | 4 | EFO_0004279 | |
| Disease | Leber congenital amaurosis | 4.52e-03 | 16 | 187 | 2 | cv:C0339527 | |
| Disease | vision disorder | 4.52e-03 | 16 | 187 | 2 | MONDO_0021084 | |
| Disease | pro-hydroxy-pro measurement | 4.52e-03 | 16 | 187 | 2 | EFO_0021132 | |
| Disease | anthranilic acid measurement | 4.52e-03 | 16 | 187 | 2 | EFO_0010460 | |
| Disease | Blood Coagulation Disorders | 4.52e-03 | 16 | 187 | 2 | C0005779 | |
| Disease | Idiopathic pulmonary arterial hypertension | 4.52e-03 | 16 | 187 | 2 | C3203102 | |
| Disease | Polyposis, Adenomatous Intestinal | 4.52e-03 | 16 | 187 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 4.52e-03 | 16 | 187 | 2 | C2713443 | |
| Disease | revision of total joint arthroplasty, aseptic loosening | 4.52e-03 | 16 | 187 | 2 | EFO_0010725, EFO_0020974 | |
| Disease | serum albumin measurement | 4.69e-03 | 592 | 187 | 10 | EFO_0004535 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TEDRVPKGSYAFHTL | 206 | Q9HBT8 | |
| IGELYGLSESSGPHT | 416 | Q5FVE4 | |
| DTGHPYLFVSEDKRS | 306 | Q96KV6 | |
| HSPGRGSLDEGYKAS | 66 | Q9NTU4 | |
| GETPLLTASARGYHD | 511 | P53355 | |
| LKHYRGPAGDATVAS | 521 | Q15758 | |
| SSGGLELYGEPRHTT | 3816 | Q99996 | |
| DTYSGKREPFSGDHS | 31 | P15514 | |
| TLHPGFYGSSREAFT | 231 | P16442 | |
| GDFREYSTVSHPIAK | 1936 | P13611 | |
| SLSDRYVSHFETEGP | 1506 | P0C0L5 | |
| TLGGHSFEPSSDGDY | 306 | O95076 | |
| GYRHDSSTAVAGSPR | 701 | Q9H1I8 | |
| LAEHSPLGSGAYRSV | 956 | P54756 | |
| SSASPGGVDYILHGS | 4441 | Q8WXG9 | |
| LEAHADKPVATYSGG | 4846 | Q86UQ4 | |
| THSLLPGTENSGYFR | 121 | Q13489 | |
| SKESGYTVLHGFPPS | 301 | O75689 | |
| EGTFLVRDSTHPSYL | 101 | Q9NSE2 | |
| SYHFSAGFGSPIEDK | 646 | Q5W041 | |
| YSFGVEARDHGTPAL | 576 | Q9HCU4 | |
| SEEEYGSRHGSPKHT | 1261 | Q9Y4F5 | |
| RRTEEKYGGDSDHPS | 261 | Q8WYQ5 | |
| PKSGTVIHSDRFDTY | 196 | Q8WUJ3 | |
| TGYHLDSKTPGPRFD | 901 | Q96F81 | |
| PASGGIFSSDYKRHD | 26 | Q13367 | |
| GEKYELHAGTESTPS | 181 | Q9UKA8 | |
| TKIFVGGLPYHTTDA | 11 | Q9BX46 | |
| FTDDKGAYSVGPLHS | 831 | P69849 | |
| FYTGAVLRHPGSLAS | 221 | Q8TE59 | |
| SPDGTVLATASHDGY | 306 | Q6P2E9 | |
| RYSLHGSDRSFPSLG | 506 | P23458 | |
| YVSGGRSSSHDFLAP | 536 | Q9Y573 | |
| HPETGTGTAYEGFLS | 941 | Q6DT37 | |
| VAGSGRRSDPGHYSF | 21 | P28062 | |
| CPYSKTADGFETHLG | 131 | Q96NR8 | |
| SAGSPTVGRYIADHS | 241 | Q8N612 | |
| GDPHITTLDGVSYTF | 4686 | Q99102 | |
| ISYHLASPADGFSVD | 2411 | Q96JQ0 | |
| SLRGGHAGTTYIFSK | 81 | P58400 | |
| FTDDKGAYSVGPLHS | 831 | Q5JPE7 | |
| TGEAGHPSADVLKYT | 856 | Q12913 | |
| HPDYSFGELSRLVGT | 1401 | Q86U86 | |
| VSSEHYAASDRESPG | 831 | Q96RG2 | |
| LKYFHTSVSRPGRGE | 26 | P13747 | |
| YLSTSPLERDGGAAH | 396 | P56524 | |
| DTFSGDRSKPLPYGH | 236 | Q3ZCV2 | |
| FDRTGLGTHTIPDYE | 256 | Q5TKA1 | |
| KSHGDLSSRRSDGYP | 561 | P08235 | |
| REAEHGYASVLPFDG | 21 | Q14582 | |
| FGTDVKEVDPAGHSY | 161 | P43362 | |
| YHEKGAEGPSSVRFL | 471 | P54760 | |
| SGSRATGFPDITFKH | 786 | Q38SD2 | |
| GEPITASLGTDGSHY | 276 | Q16555 | |
| ITTIEYGHAAPGTDS | 91 | Q9H427 | |
| GLFPESSYGERHLDD | 51 | Q8N7B1 | |
| ETTVTGSDPFYDRFH | 871 | O60333 | |
| VLSGGSHPFGDSLYR | 716 | Q76MJ5 | |
| HSALRYGGSFAELGP | 131 | O15054 | |
| RHDYVEDSSEGGLSP | 811 | Q9UPA5 | |
| LARSVSGKTPGDFYD | 1731 | Q3V6T2 | |
| TAPSGSEYRHPGASD | 141 | O43660 | |
| RGILKPGSTHSYEFD | 391 | P54315 | |
| GPEKEGEGHSYFSST | 691 | Q07343 | |
| GFESERRGSHPYIDF | 76 | Q13946 | |
| DGDTVSVHRPSFYAD | 371 | O14986 | |
| AGYPRSGTSRFIHTD | 761 | Q8IVL0 | |
| GHSSGYDSRSARAFP | 411 | Q6UN15 | |
| RGPYESRSGHSSVFG | 1271 | Q86YZ3 | |
| RGPYESRSGHSSVFG | 1741 | Q86YZ3 | |
| RGPYESRSGHSSVFG | 2211 | Q86YZ3 | |
| RGPYESRLGHSSVFG | 2681 | Q86YZ3 | |
| FTDDKGAYSVGPLHS | 831 | Q15155 | |
| LLGSSERDFFYHPET | 66 | Q9NZV8 | |
| GQSSYTFDHRIKPEA | 106 | Q05315 | |
| YEGLAHSSSKGREAP | 1441 | Q9ULI4 | |
| NLEEGSPGSGTYTRH | 16 | Q9Y3B2 | |
| AKFHIPSTVYDSAGR | 81 | O75023 | |
| GSSLGFKRSYEEHIP | 1346 | P06213 | |
| DPIRGFGSYHPSASS | 1446 | Q9UKK3 | |
| GRVAELEHGSSAYSP | 276 | O95502 | |
| GGHVTFRPVSASSYL | 596 | Q96M63 | |
| RGYEKSVIHSGPFTE | 716 | Q9GZU2 | |
| DFTHPNGTGDKSIYG | 66 | P0DN37 | |
| HGKSDLSRGSPYRES | 616 | Q9H7U1 | |
| GEPITASLGTDGSHY | 276 | O14531 | |
| GGDLVVSYPFDFSKH | 381 | Q66K79 | |
| GAHTGSSLEDFPYGT | 536 | P20023 | |
| DPNHSEGSTTLLEGY | 546 | P16070 | |
| EGSTTLLEGYTSHYP | 551 | P16070 | |
| SGDPHYTTFDGRRFD | 2456 | Q9Y6R7 | |
| GADEAVPRHDSSYGT | 51 | Q9P0K9 | |
| VPRHDSSYGTFAGEF | 56 | Q9P0K9 | |
| DESYSEAFTLGVPHG | 1096 | Q8IZJ3 | |
| VAFHPDGKSYSSGGE | 291 | Q13347 | |
| YGISDHKPVSGTFDL | 306 | Q9BT40 | |
| STFGSGEPRHEAYIS | 211 | P35453 | |
| VFEGPSFGYTEHSVR | 181 | O60941 | |
| GARAHYDGFSLEPES | 356 | Q8NI99 | |
| LRYITARSFSPHAGG | 121 | Q8NFW1 | |
| SVDYRHKFSLPSVDG | 201 | P31785 | |
| HESYARSDTKLGPEA | 486 | Q9NR34 | |
| IALIGTSRGSYPFSH | 11 | Q86SG7 | |
| RPLHVRTTSDGGYSF | 336 | P05111 | |
| GVDARHPSFFLYRSG | 251 | P25774 | |
| HTAALTGALPRYGTS | 366 | O14640 | |
| STTFTDAHVEPGRKY | 701 | Q86VF2 | |
| TYGTLSGLVASHEDP | 196 | Q9NT22 | |
| GYGSSPTFSQTDREH | 21 | Q12929 | |
| SYSHKEDASAFPGKR | 341 | Q5W0V3 | |
| SGPLDRESVEHYFFG | 711 | Q9NYQ7 | |
| ITGLPSSFSYHEASG | 366 | P82279 | |
| GPHVTRFKDTYFVTG | 421 | P00742 | |
| VTLYFGEPDSTGHRY | 191 | Q6UWV6 | |
| DGTSDRPYSHALVAG | 31 | P61353 | |
| HSGDTPTTGYVIEAR | 1926 | Q7Z5N4 | |
| YESPNHRGKDSSFLA | 46 | Q5JQF7 | |
| SFQHSSSLGRELPYD | 41 | Q8NC60 | |
| SLSDRYVSHFETEGP | 1506 | P0C0L4 | |
| LPSHVSLTGESDGGY | 726 | P09619 | |
| HSLYSGIEGLDESPS | 716 | Q8TEW0 | |
| SGKGSYTLVGRHEPE | 171 | Q6ZRI0 | |
| YTLVGRHEPEGQSFS | 176 | Q6ZRI0 | |
| RKRDSGHVSPGTFFD | 946 | Q10571 | |
| RAPSLGHLESSDYAG | 1466 | P0C091 | |
| GHLESSDYAGEPIAS | 1471 | P0C091 | |
| LESASDHPIASYRGT | 456 | Q9Y4G2 | |
| GRDFLSGPDYDHVTG | 666 | Q6ZW31 | |
| AEYAHRGFSEVKTPT | 341 | Q9BW92 | |
| ISPRYDPDSGHDSGA | 626 | Q7Z4K8 | |
| RRHITASGGSESGYP | 266 | Q9NRR2 | |
| FVSSHYILESPGGVS | 116 | Q13671 | |
| PARAVSRHFEDTSYG | 321 | Q9Y6P5 | |
| GLRYSVEASSPGHGS | 436 | Q8TEQ0 | |
| DEGISSSAISPHGRY | 306 | Q96DN5 | |
| STFTKRDPRGEYEEH | 1626 | P12259 | |
| AHSPSLGSEYFIRLE | 521 | Q6ZMQ8 | |
| SKPRHGPTGVDTFAY | 956 | Q58EX7 | |
| GYSPLGKTREFSSSH | 121 | Q9Y581 | |
| IDFGSGALLHDEPYT | 181 | Q9P1W9 | |
| PSFHFDGSGYSVVEK | 2306 | P25391 | |
| GHAETPVYRFSLADG | 326 | Q9Y6Q9 | |
| PEGTFLIRDSSHSDY | 66 | O14508 | |
| VGTDGTPKVHTDDFY | 21 | O43166 | |
| RHTGALPLFREYGST | 191 | O60292 | |
| PDSSTLKIFYGRGDH | 921 | O60292 | |
| APSSGEEGELHYATL | 436 | Q9NYZ4 | |
| GDRPHAYFGPEASAS | 256 | Q9UJ37 | |
| DAYVFPGDGASHTKV | 56 | Q9Y535 | |
| HSDPESDFYRGKGEP | 131 | O94864 | |
| ELADSSGLYHEGSPS | 156 | Q8NCF5 | |
| SSLSGYPLGRADFDH | 116 | Q86SQ0 | |
| FHPTVTGESLYGDFT | 241 | Q96A09 | |
| ERGEEKGTSSPDYRH | 986 | Q66K14 | |
| GRAYGAKTDTFHPER | 846 | Q9UM73 | |
| TSNSGDPHKGFSVDY | 71 | O75969 | |
| GYKGTFTLHVPQDTE | 521 | O75339 | |
| IYGSIDFGKTVVSHP | 501 | O75153 | |
| RPYTEFPFGQHSSGE | 81 | Q6PCB0 | |
| FSIGDTTELEPYLHG | 271 | A0AVT1 | |
| SAGLRPGALATEHYS | 36 | Q8NBP0 | |
| RSYKRTFSEPGDHPG | 246 | Q9HA47 | |
| SVLSGISLYDPRDHG | 1041 | P61129 | |
| HGTFSYLDDVPFKTG | 11 | Q9NZ09 | |
| SLRFSPGYAIEKHSG | 171 | P06133 | |
| FSGDGPISTVRLHYR | 471 | P35590 | |
| DGPRHSASDDYFIPS | 351 | Q14515 | |
| GTKPVSYHERALFSD | 461 | Q9NYB5 | |
| SYHSGSVFSARDRDP | 4161 | P22105 | |
| SDVFRVAEFPHGYGS | 1286 | Q92626 | |
| PFRGSYSFDDHITDS | 556 | Q5T1R4 | |
| PEDHGSSYEGSVSFR | 16 | Q52M93 | |
| LDPGTRDSYGATSHL | 6 | Q5T6S3 | |
| GSAMSRPIIHFGSDY | 131 | P04156 | |
| PHRGYSISAGSDADT | 106 | Q9P273 | |
| SPTLAASSYHGDVVG | 1876 | O95359 | |
| HTYPDGTYTGRIFLE | 111 | Q495A1 | |
| SRGDSTYTFHEGPVL | 171 | Q96A28 | |
| YIFDSLRGSDPSTHQ | 256 | Q8TC07 | |
| DKYSFPSGHATRAAL | 206 | Q8IY26 | |
| PEDHGSSYEGSVSFR | 16 | Q6P3V2 | |
| GYASPDRTHVLAAGK | 1141 | O43379 | |
| THTAFPGTDKLLSGY | 541 | Q96F45 | |
| HSGKEYFRVPDSATF | 3131 | Q7Z7G8 | |
| STAYNLTHTFRDPGD | 296 | Q8N3G9 | |
| IRFYAGKPHSTGSSE | 521 | O60346 | |
| STAVPYGSFKHVDTR | 31 | Q9UHJ3 | |
| YAGSRTHPDHFGSLE | 146 | Q6UXY8 | |
| ITEDRVPKGSYAFHT | 206 | P0CG31 | |
| EAPSSVGEDHYFRSP | 356 | P57082 | |
| EQTYTFHGALKEGPS | 166 | A0PK05 | |
| HRRVYSDEGGKLSPF | 111 | Q9Y2B5 | |
| YLAVHFPGSSLRDEG | 1206 | Q5JPB2 | |
| SLSFSPGYTFEKHSG | 171 | P16662 | |
| GKHSEFLTVPAGSYS | 1001 | P31629 | |
| VRSKSFDYGNLSHAP | 1046 | P31629 | |
| RPEEGSHASLSSGYA | 141 | Q7Z2V1 | |
| GLGLPDYTSGVSFHD | 1061 | Q562E7 | |
| GLRPDEFLGLTHTYS | 191 | O15321 | |
| FGLQTTSADRSDHYP | 586 | Q5THJ4 | |
| RTSPEGYAHFTLSGD | 2741 | Q5THJ4 | |
| YDAKDLHPGVSSRFS | 71 | A0A075B6H8 | |
| PHSIGSASSIDGLYD | 991 | Q13224 | |
| TYDGTTPLHIAAGRG | 716 | P19838 |